The Predictive Value of the 4Ts and HEP Score at Recommended Cutoffs in Patients With Mechanical Circulatory Support Devices.

anticoagulation extracorporeal membrane oxygenation heart-assist devices heparin intra-aortic balloon pumping platelet factor 4

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
07 2022
Historique:
received: 15 12 2021
revised: 13 01 2022
accepted: 21 02 2022
pubmed: 26 3 2022
medline: 9 6 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

Despite the increasing utilization of mechanical circulatory support (MCS) devices, the 4Ts and heparin-induced thrombocytopenia (HIT) Expert Probability (HEP) scores have not been validated in patients with suspected HIT requiring MCS. A retrospective cohort study. At a tertiary university hospital. Adults with suspected HIT requiring any MCS. A diagnostic investigation of HIT. Of the 299 patients included, there were 374 diagnostic investigations of HIT, of which 32 (8.6%) were HIT-probable (heparin PF4 immunoassay optical density ≥1 or positive serotonin release assay). The 4Ts score ≥4 demonstrated a pretest sensitivity of 0.56 (95% confidence interval [CI]: 0.39-0.72) and specificity of 0.8 (95% CI: 0.75-0.83). The HEP score ≥3 demonstrated a pretest sensitivity of 0.31 (95% CI: 0.18-0.49) and specificity of 0.83 (95% CI: 0.79-0.87). The area under the receiver operating characteristic curve for the 4Ts and HEP scores were 0.68 (95% CI: 0.63-0.73) and 0.63 (95% CI: 0.59-0.68), respectively, and were not statistically different (p = 0.21). In patients with an intra-aortic balloon pump, neither the 4Ts nor HEP score had discriminatory ability to differentiate probable HIT. The HEP score had no discriminatory ability in patients with concomitant MCS devices. The 4Ts and HEP scores have a modest predictive performance for probable HIT in patients requiring MCS devices. A low 4Ts or HEP score does not reliably rule out HIT in patients requiring MCS, and clinical suspicion for HIT should be investigated, utilizing laboratory tests in this population.

Identifiants

pubmed: 35331630
pii: S1053-0770(22)00139-2
doi: 10.1053/j.jvca.2022.02.030
pii:
doi:

Substances chimiques

Anticoagulants 0
Heparin 9005-49-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1873-1879

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Shawn J Kram (SJ)

Department of Pharmacy, Duke University Hospital, Durham, NC. Electronic address: shawn.kram@duke.edu.

Arzo Hamidi (A)

Department of Pharmacy, Rush University Medical Center, Chicago, IL.

Bridgette L Kram (BL)

Department of Pharmacy, Duke University Hospital, Durham, NC.

Gowthami Arepally (G)

Department of Hematology, Duke University Hospital, Durham, NC.

Jerrold H Levy (JH)

Departments of Anesthesiology and Surgery (Cardiothoracic), Duke University Hospital, Durham, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH